NextCure Inc
SWB:2US
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCure Inc
SWB:2US
|
US |
|
Inmocemento SA
F:X8G
|
ES |
|
S & S Power Switchgear Ltd
NSE:S&SPOWER
|
IN |
|
First Lithium Minerals Corp
OTC:FLMCF
|
CA |
|
P
|
Pharmadrug Inc
F:G111
|
CA |
|
C
|
Centaurus Energy Inc
OTC:CTARF
|
CA |
|
G
|
Grays Leasing Ltd
KAR:GRYL
|
PK |
|
Coast Copper Corp
OTC:COCCF
|
CA |
|
F
|
Fixer Inc
TSE:5129
|
JP |
|
Orpea SA
PAR:ORP
|
FR |
|
Quinsam Capital Corp
F:0Q4
|
CA |
|
A
|
Accrol Group Holdings PLC
F:0AE
|
UK |
|
G
|
Gentherm Inc
SWB:QA4A
|
US |
|
F
|
First Resources Ltd
SWB:5F1
|
SG |
|
A
|
Areti Web Innovations Inc
OTC:CCVL
|
US |
|
B
|
Bathurst Resources Ltd
OTC:BTURF
|
NZ |
|
R
|
Repsol SA
XHAN:REP
|
ES |
|
TSI Holdings Co Ltd
TSE:3608
|
JP |
|
O
|
OncoSec Medical Inc
F:ONM2
|
US |
|
I
|
Imerys SA
DUS:IY4
|
FR |
|
Great Western Mining Corporation PLC
F:8GW0
|
IE |
|
X
|
Xigem Technologies Corp
F:VZ6
|
CA |
Bankruptcy Probability
NextCure Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NextCure Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
N
|
NextCure Inc
NASDAQ:NXTC
|
27.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
457.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
230.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NextCure Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NextCure Inc has no debt.
You can find a full breakdown on its Balance Sheet.
